Small Intestinal Bacterial Overgrowth: Microbiome Dysregulation, Gut-Brain Axis Disruption, and Systemic Consequences.
Ayman Furqan, Muhammad Tauseef Sultan, Muhammad Usman Khalid, Muhammad Waqar, Muhammad Maaz, Laiba Tanvir, Rameen Naeem, Mutjardah Zarrish, Sabrin R M Ibrahim, Gamal A Mohamed, Md Sakhawot Hossain, Hagar M Mohamed
Molecular nutrition & food research
42378001
July 1, 2026
Quality Indicators
Abstract Only: Full text of this study is not publicly available. This summary is based on the abstract only and may be less detailed than usual.
AI-Generated Summary: This summary was created by AI and may contain errors. Always consult healthcare professionals and read the original study for medical decisions.
Study Summary
AI-generated overview of this research
Quick Summary
This review examines SIBO (small intestinal bacterial overgrowth), a condition where too many bacteria colonize the small intestine, causing poor digestion and nutrient absorption. The authors explore how SIBO affects multiple body systems beyond the gut—including the brain, heart, skin, and immune system—and review current treatment approaches including antibiotics, dietary changes, and natural supplements.
What Was Studied
This is a narrative review article that examines the causes, effects, and treatments of SIBO. The authors analyzed existing research on how SIBO develops, its connections to other health conditions through the gut-brain axis (the communication pathway between the digestive system and nervous system), and current management strategies including medications, dietary interventions like low-FODMAP diets, and supplements such as berberine and oregano oil.
How the Study Was Conducted
The authors conducted a literature review synthesizing published research on SIBO's pathophysiology (how the disease develops), diagnostic methods, and treatment approaches. They evaluated evidence quality, distinguishing between well-supported clinical findings and preliminary observational or laboratory-based studies. Full methodology not publicly available — summary based on abstract only.
Key Findings
- SIBO causes systemic effects throughout the body, contributing to metabolic disorders, neurological problems, cardiovascular conditions, skin diseases, and autoimmune conditions beyond just digestive symptoms
- Current treatments include the antibiotic rifaximin, low-FODMAP and biphasic diets, and natural supplements (berberine, oregano oil, peppermint oil, garlic, vitamins, and magnesium), though all face challenges with high recurrence rates and antibiotic resistance
- SIBO develops through multiple interconnected mechanisms including gut-brain axis disruption, microbial imbalance, oxidative stress (cellular damage from unstable molecules), slow intestinal movement, structural abnormalities, low stomach acid, bile acid problems, and immune dysfunction
- Natural supplement and dietary approaches show promise as patient-centered alternatives but need stronger clinical validation through rigorous trials
Important Limitations
- As a review article, this study does not present new original research data or patient outcomes
- The authors identify that current evidence for natural supplements and dietary interventions requires stronger clinical validation, suggesting existing studies may lack sufficient rigor
- Full text not publicly available — summary based on abstract only
Was this summary helpful?
Related Studies
Coming soon: See other studies on similar topics